Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4099380
Max Phase: Preclinical
Molecular Formula: C28H34N5NaO8
Molecular Weight: 569.62
Molecule Type: Small molecule
Associated Items:
ID: ALA4099380
Max Phase: Preclinical
Molecular Formula: C28H34N5NaO8
Molecular Weight: 569.62
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CN)O[C@@](OCCCn2cc(-c3ccc(-c4ccccc4)cc3)nn2)(C(=O)[O-])C[C@@H]1O.[Na+]
Standard InChI: InChI=1S/C28H35N5O8.Na/c1-17(34)30-24-22(35)14-28(27(38)39,41-26(24)25(37)23(36)15-29)40-13-5-12-33-16-21(31-32-33)20-10-8-19(9-11-20)18-6-3-2-4-7-18;/h2-4,6-11,16,22-26,35-37H,5,12-15,29H2,1H3,(H,30,34)(H,38,39);/q;+1/p-1/t22-,23+,24+,25+,26+,28+;/m0./s1
Standard InChI Key: FCRDYJKYWSDCAY-GWDSEHCUSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 569.62 | Molecular Weight (Monoisotopic): 569.2486 | AlogP: 0.13 | #Rotatable Bonds: 12 |
Polar Surface Area: 202.28 | Molecular Species: ZWITTERION | HBA: 11 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 13 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.02 | CX Basic pKa: 9.21 | CX LogP: -1.70 | CX LogD: -1.71 |
Aromatic Rings: 3 | Heavy Atoms: 41 | QED Weighted: 0.16 | Np Likeness Score: -0.05 |
1. Prescher H, Frank M, Gütgemann S, Kuhfeldt E, Schweizer A, Nitschke L, Watzl C, Brossmer R.. (2017) Design, Synthesis, and Biological Evaluation of Small, High-Affinity Siglec-7 Ligands: Toward Novel Inhibitors of Cancer Immune Evasion., 60 (3): [PMID:28103033] [10.1021/acs.jmedchem.6b01111] |
Source(1):